Literature DB >> 10331565

Detection of Helicobacter DNA in bile from bile duct diseases.

I H Roe1, J T Kim, H S Lee, J H Lee.   

Abstract

Several species of Helicobacter colonize the hepatobiliary tract of animals and cause hepatobiliary diseases. The aim of this study is to investigate Helicobacter found in the biliary tract diseases of humans. Thirty-two bile samples (15 from bile duct cancer, 6 from pancreatic head cancer, and 11 from intrahepatic duct stone) were obtained by percutaneous transhepatic biliary drainage. Polymerase chain reaction analysis using Helicobacter specific urease A gene and 16S rRNA primers, bile pH measurement, and Helicobacter culture were performed. Helicobacter DNA was detected in 37.5%, and 31.3% by PCR with ureA gene, and 16S rRNA, respectively. The bile pH was not related to the presence of Helicobacter. The cultures were not successful. In conclusion, Helicobacter can be detected in the bile of patients with bile duct diseases. The possibility of pathogenesis of biliary tract diseases in humans by these organisms will be further investigated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331565      PMCID: PMC3054363          DOI: 10.3346/jkms.1999.14.2.182

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  8 in total

Review 1.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Identification of Helicobacter pylori in Gallstone, Bile, and Other Hepatobiliary Tissues of Patients with Cholecystitis.

Authors:  Jin-Woo Lee; Don Haeng Lee; Jung Il Lee; Seok Jeong; Kye Sook Kwon; Hyung Gil Kim; Yong Woon Shin; Young Soo Kim; Mi Sook Choi; Si Young Song
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

3.  Immune responses to bile-tolerant helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors.

Authors:  Olga Ananieva; Ingrid Nilsson; Tamara Vorobjova; Raivo Uibo; Torkel Wadström
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Pancreatic cancer after remote peptic ulcer surgery.

Authors:  M Tascilar; B P van Rees; P D J Sturm; G N J Tytgat; R H Hruban; S N Goodman; F M Giardiello; G J A Offerhaus; A C Tersmette
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

5.  Modalities of testing Helicobacter pylori in patients with nonmalignant bile duct diseases.

Authors:  Milutin Bulajic; Bojan Stimec; Miroslav Milicevic; Matthias Loehr; Petra Mueller; Ivan Boricic; Nada Kovacevic; Mirko Bulajic
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Comparative proteome analysis of untreated and Helicobacter pylori-treated HepG2.

Authors:  Yan Zhang; Xue-Gong Fan; Ren Chen; Zhi-Qiang Xiao; Xue-Ping Feng; Xue-Fei Tian; Zhao-Hui Chen
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

7.  Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method.

Authors:  Tahereh Pirouz; Leila Zounubi; Hussein Keivani; Nasser Rakhshani; Mahshid Hormazdi
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

8.  Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract.

Authors:  C de Martel; M Plummer; J Parsonnet; L-J van Doorn; S Franceschi
Journal:  Br J Cancer       Date:  2008-11-25       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.